| 中国人用疫苗上市情况分析与展望 |
| |
| 引用本文： | 王冠杰,邵明立.中国人用疫苗上市情况分析与展望[J].中国计划免疫,2021(1). |
| |
| 作者姓名： | 王冠杰 邵明立 |
| |
| 作者单位： | 沈阳药科大学;中国食品药品检定研究院;中国药品监督管理研究会 |
| |
| 摘 要： | 本文分析了中国2019年批签发的人用疫苗种类、数量、生产企业等,对比了国内外疫苗行业发展趋势,展望了中国疫苗发展前景。中国免疫规划疫苗发展平稳,非免疫规划疫苗有较大发展空间,多联多价疫苗、治疗性疫苗和应急疫苗发展迅速。中国需鼓励疫苗产业研发与生产,进一步提高疫苗上市后的安全、有效和合理可及性。
|
| 关 键 词： | 疫苗 批签发 上市 展望 |
Marketing and prospects for human vaccines in China |
| |
| Wang Guanjie,Shao Mingli.Marketing and prospects for human vaccines in China[J].Chinese Journal of Vaccines and Immunization,2021(1). |
| |
| Authors: | Wang Guanjie Shao Mingli |
| |
| Institution: | (Shenyang Pharmaceutical University,Shenyang 110016,Liaoning,China;National Institute for Food and Drug Control,Beijing 102629,China;China Society for Drug Regulation,Beijing 100082,China) |
| |
| Abstract: | In this article,we analyze types,quantities,and manufacturers of human vaccines that were released for Chinese markets in 2019;we compare development trends of Chinese and international vaccines and discuss prospects for development of Chinese vaccines.In China,National Immunization Program(NIP)vaccines maintain steady development while non-NIP vaccines have a larger development space;combination or multivalent vaccines,therapeutic vaccines,and emergency vaccines are developed rapidly.The Chinese government should encourage vaccine manufacturers to conduct research and develop vaccines to improve safety,effectiveness and accessibility of vaccines during post-marketing periods. |
| |
| Keywords: | Vaccine Lot release Marketing Prospect |
| 本文献已被 CNKI 维普 等数据库收录！ |
|
